The National Times - Toyota names new CEO, hikes profit forecasts

Toyota names new CEO, hikes profit forecasts


Toyota names new CEO, hikes profit forecasts
Toyota names new CEO, hikes profit forecasts / Photo: © AFP

Toyota has named a new CEO to "accelerate" decision-making, the Japanese auto giant said Friday as it hiked its profit and sales forecasts for the current fiscal year despite the impact of US tariffs.

Change text size:

Current finance chief Kenta Kon will take over from chief executive Koji Sato on April 1 after three years in charge, the firm said.

"This change in roles is intended to accelerate management decision-making in response to changes in the internal and external environment," Toyota said.

The move would also help "establish a structure that will enable Toyota to fully carry out its mission of contributing to society through industry", it added.

The announcement came as the firm expects to see net profit of 3.57 trillion yen ($22.8 billion) for the year ending in March, down 25.1 percent year-on-year but up from the 2.93 trillion yen previously anticipated.

Despite the "negative impact of US tariffs that newly arose this fiscal year, we have reduced the extent of the profit decline by implementing cost reductions and marketing efforts", the firm said in a statement.

Sales are expected to climb 4.1 percent year-on-year to 50 trillion yen, a slight upwards revision.

Operating profit is forecast to hit 3.8 trillion yen, up from the previous projection of 3.4 trillion yen.

However, Toyota said the September-December quarter saw net and operating profit fall despite a rise in sales, largely because of a "tariff impact" that increased expenses.

- Record sales -

The firm announced last month that global sales hit a new record in 2025, helping it retain its title as the world's top automaker and widen the gap with German rival Volkswagen.

The overall increase came despite flat sales in China, a crucial market where Toyota faces intensifying competition from local automakers including electric-car champion BYD.

US sales climbed eight percent despite the 25-percent tariff on Japanese auto exports imposed by Washington between April and mid-September, when a 15-percent cap kicked in.

The United States is a key market where Toyota generates almost a quarter of its sales. But of the 2.52 million vehicles it sold there in 2025, only 1.39 million were produced in the country.

Even so, Toyota increased output last year by 10 percent at its factories in the United States, where it produces increasingly popular hybrid vehicles.

To keep exporting to the United States on competitive terms, Japanese automakers have had to slash prices.

kh-jug-stu-aph/ami

L.Graham--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: